Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
Publication
, Journal Article
Burstein, B; Altobelli, KK; Williams, K; Cannon, CP; Pencina, MJ; Sniderman, AD; Thanassoulis, G
Published in: Circulation
November 7, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
November 7, 2017
Volume
136
Issue
19
Start / End Page
1860 / 1862
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Time Factors
- Risk Factors
- Randomized Controlled Trials as Topic
- Protective Factors
- Primary Prevention
- Practice Guidelines as Topic
- Patient Selection
- Nutrition Surveys
Citation
APA
Chicago
ICMJE
MLA
NLM
Burstein, B., Altobelli, K. K., Williams, K., Cannon, C. P., Pencina, M. J., Sniderman, A. D., & Thanassoulis, G. (2017). Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. Circulation, 136(19), 1860–1862. https://doi.org/10.1161/CIRCULATIONAHA.117.029102
Burstein, Barry, Kathleen K. Altobelli, Ken Williams, Christopher P. Cannon, Michael J. Pencina, Allan D. Sniderman, and George Thanassoulis. “Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.” Circulation 136, no. 19 (November 7, 2017): 1860–62. https://doi.org/10.1161/CIRCULATIONAHA.117.029102.
Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, et al. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. Circulation. 2017 Nov 7;136(19):1860–2.
Burstein, Barry, et al. “Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.” Circulation, vol. 136, no. 19, Nov. 2017, pp. 1860–62. Pubmed, doi:10.1161/CIRCULATIONAHA.117.029102.
Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. Circulation. 2017 Nov 7;136(19):1860–1862.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
November 7, 2017
Volume
136
Issue
19
Start / End Page
1860 / 1862
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Time Factors
- Risk Factors
- Randomized Controlled Trials as Topic
- Protective Factors
- Primary Prevention
- Practice Guidelines as Topic
- Patient Selection
- Nutrition Surveys